Bio-Rad Laboratories BIO Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
Based on trailing twelve months.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's return on equity?
- Bio-Rad Laboratories (BIO) reported return on equity of 2.5% in Q1 2026.
- How has Bio-Rad Laboratories's return on equity changed year-over-year?
- Bio-Rad Laboratories's return on equity increased by 109.1% year-over-year, from -27.5% to 2.5%.
- What is the long-term trend for Bio-Rad Laboratories's return on equity?
- Over 5 years (2020 to 2025), Bio-Rad Laboratories's return on equity has grown at a -25.9% compound annual growth rate (CAGR), from 48.7% to 10.8%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.